short interest went to about 4 million shares on THER therasense about a year after its ipo in 2001, and hit close to 5 per share. had gone public at 19 (first day closing about 25)
then it was bought out a year later - at 27
so whoever was smart enough to load up under 10 on that one was nicely rewarded by the abbott laboratories buyout
http://www.advfn.com/p.php?pid=qkchart&symbol=N%5ETHER
(put the period to 5 years in the drop-down box to see the chart)
now, shorts are, as of oct 10 trade day, 4.5 million shares on dxcm - up from about 300 thou short interest in jan
who knows what this spec will do - I only know one thing:
I love this product, and until a cure for diabetes is found I'm using it as long as I can.
in my humble opinion, insurance companies in general will cover, when enough people ask.
just don't get it how more of the 1 million people that juggle glucose levels in the US alone are not buying cgm